Pharmaceutical compositions comprising recombinant troponin subunits
First Claim
Patent Images
1. A pharmaceutical composition comprising an effective amount of a recombinant peptide for inhibiting angiogenesis, wherein the peptide is selected from the group consisting of fast-twitch troponin subunit C (SEQ ID NO:
- 1), fast-twitch troponin subunit I (SEQ ID NO;
2), fast-twitch troponin subunit T (SEQ ID NO;
3), and cartilage troponin subunit I (SEQ ID NO;
17); and
a pharmaceutically acceptable carrier.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of recombinant troponin C, I or T subunits for the treatment of diseases or disorders involving abnormal angiogenesis.
17 Citations
36 Claims
-
1. A pharmaceutical composition comprising an effective amount of a recombinant peptide for inhibiting angiogenesis, wherein the peptide is selected from the group consisting of fast-twitch troponin subunit C (SEQ ID NO:
- 1), fast-twitch troponin subunit I (SEQ ID NO;
2), fast-twitch troponin subunit T (SEQ ID NO;
3), and cartilage troponin subunit I (SEQ ID NO;
17); and
a pharmaceutically acceptable carrier. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)
- 1), fast-twitch troponin subunit I (SEQ ID NO;
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeChildren's Medical Center Corporation
-
Original AssigneeChildren's Medical Center Corporation
-
InventorsLanser, Marc E., Wiederschain, Dmitri G., Thorn, Richard M., Moses, Marsha A.
-
Primary Examiner(s)Nguyen, Dave T.
-
Assistant Examiner(s)Nguyen, Quang
-
Application NumberUS09/612,421Time in Patent Office1,096 DaysField of Search514/2, 514/12, 435/69.1, 435/70.1, 530/350US Class Current424/1.11CPC Class CodesA61K 38/1709 from mammalsA61P 27/02 Ophthalmic agentsA61P 35/00 Antineoplastic agentsC07K 14/4716 Muscle proteins, e.g. myosi...
